Literature DB >> 17318952

Lung cancer trends in Vojvodina.

V Petrović1, M Miladinov-Mikov, A Mandić.   

Abstract

PURPOSE: Lung cancer in Vojvodina is the leading form of cancer as well as the leading cause of cancer deaths in men. It ranks 2nd in cancer deaths in women in Vojvodina. The goal of this report was to study lung cancer in Vojvodina in th period 1989-1998 by analysing the crude and age-standardized incidence and mortality rates in the male and female population.
MATERIALS AND METHODS: Data used for analyses were provided by the Cancer Registry of Vojvodina from the Institute of Oncology Sremska Kamenica. Data included number of cases and deaths of lung cancer, by age groups in 5 year intervals and by the municipalities for male and female population separately. Descriptive epidemiological method was used.
RESULTS: An increasing tendency of linear trend of lung cancer incidence in males based on crude and age-standardized incidence rates was found. The trend of lung cancer incidence in males was highly intense and extremely unfavorable. In females, an increasing tendency of linear trend of lung cancer incidence based on crude and age-standardized incidence rates was also found; this was not as intense but it was unfavorable. An increasing tendency of linear trend of lung cancer mortality based on crude and age-standardized mortality rates in both sexes was registered, which was not intense, but it was unfavorable.
CONCLUSION: Vojvodina is a region with high incidence and mortality rates in comparison to neighboring and European Union (EU) countries both in male and female population.

Entities:  

Mesh:

Year:  2006        PMID: 17318952

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  1 in total

1.  Lung cancer in women: histological type and patient age from 1985 to 2005.

Authors:  Jelena Stojsic; Ivan Milovanovic; Jelena Radojicic; Branislava Milenkovic
Journal:  Med Oncol       Date:  2008-11-04       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.